ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Biotechnology

Healthcare
$12.82 +0.73%

+$0.13 today

Market cap
$1.42B
Beta
0.00
52W Low $16.64High $23.21

Volume 0.65M

Average 1.06M

ADRX Total Current Assets

All assets expected to be converted to cash or used up within one year.

No reported Total Current Assets figures are available to summarize.

Total Current Assets history

Currency unavailable · from the balance sheet

No Total Current Assets data reported for this period type.

Total Current Assets vs competitors

How ADRX compares with its peers on the latest reported figures

ADRX Competitors
Total Current Assets for ADRX and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
WVEWave Life Sciences Ltd.Mar 2026$561.27M USD+117.6%+84.1%96.2%
STOKStoke Therapeutics, Inc.Mar 2026$366.68M USD-2.4%+7.8%82.7%
RNAAtrium Therapeutics, Inc.Mar 2026$285.57M USD——97.7%
ARCTArcturus Therapeutics Holdings Inc.Mar 2026$216.88M USD-22.2%-15.7%88.4%
BNTCBenitec Biopharma Inc.Mar 2026$186.02M USD+78.8%+173.4%99.5%
PRMEPrime Medicine, Inc.Mar 2026$137.89M USD-15.8%-15.1%46.8%
SLNSilence Therapeutics plcMar 2026$102.85M USD-39.4%+7.1%89.3%
MGTXMeiraGTx Holdings plcMar 2026$96.2M USD+20.4%-15.9%39.3%
PRQRProQR Therapeutics N.V.Mar 2026€87.07M EUR-41.6%-13.5%87.8%
ADRXADARx Pharmaceuticals, Inc.—— ———
Peer median (excluding ADRX) —-9.1%-3.2%88.4%

Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Intrinsic Alpha fair value

Locked

Current Price

$12.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.